PRO-FLEX Cream
- Manufacturer
- Nutri-Dyn Products Ltd. dba Professional Health Products | International Laboratories (Canada) Ltd.
- Effective date
- 2011-06-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 9
- Source
- full-release
- Hydrated at
- 2026-05-31 22:28:21
Label at a glance#
ProductPro-Flex
Active ingredientCAMPHOR (NATURAL), Menthol
Label structure9 sections
Contacts and useful links#
Websitewww.professionalhealthproducts.com
www.professionalhealthproducts.com
www.professionalhealthproducts.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients (Percent by weight) Purpose
Menthol 4.0% ............................Analgesic (Pain reliever)
Camphor 4.0% ...........................Analgesic (Pain reliever)
INDICATIONS & USAGE SECTION
Uses for the temporary relief of minor aches and joint pain associated with backpain, arthritis, strains, bruises and sprains.
WARNINGS SECTION
Warnings
- For external use only. Avoid contact with eyes. If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days,discontinue use of this product and consult a doctor.
- Do not apply to wounds or damaged skin
- Do not bandage tightly
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of the reach of children
If swallowed, get medical help or contact a poison control center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- Adults and children 2 years of age and older: Apply to affected area several times daily.
- Children under 2 years of age: Do not use, consult a doctor.
INACTIVE INGREDIENT SECTION
C13-14 isoparaffin, caprylyl glycol, cetyl alcohol, chondroitin sulfate, denatured alcohol, eucalyptus oil, glucosamine sulfate, glycerin, grape seed oil, laureth-7, methylsulfonylmethane (MSM), oil of lavender, oil of wintergreen, phenoxyethanol, polyacrylamide, polysorbate-20, sea cucumber extract, sorbic, acid, stearyl alcohol, thymol, urea, vitamin E, water
REFERENCES SECTION
Distributed by:
PROFESSIONAL HEALTH PRODUCTS
4307-49th Street Innisfail, AB CANADA T4G 1P3
1-403-227-3926
OTC - PURPOSE SECTION
Pain Reliever
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Professional Health Products
PRO-FLEX Cream
FOR
Muscle Pain/Joint Relief
(Includes MSM, Glucosamine, Chondroitin)
120 net wt. g
www.professionalhealthproducts.com
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49795-227-01 | 2025-11-13 | C162847 | 48780-1 | 960f7f55-c293-8e05-e053-dbdaa90a074a | PRO-FLEX Cream |
| 49795-227-02 | 2025-11-13 | C162847 | 48780-1 | 960f7f55-c293-8e05-e053-dbdaa90a074a | PRO-FLEX Cream |
| 49795-227-03 | 2025-11-13 | C162847 | 48780-1 | 960f7f55-c293-8e05-e053-dbdaa90a074a | PRO-FLEX Cream |
| 49795-227-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c293-8e05-e053-dbdaa90a074a | PRO-FLEX Cream |
| 49795-227-02 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c293-8e05-e053-dbdaa90a074a | PRO-FLEX Cream |
| 49795-227-03 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c293-8e05-e053-dbdaa90a074a | PRO-FLEX Cream |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAMPHOR (NATURAL) | ACTIVE INGREDIENT | N20HL7Q941 | 9 | |
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 9 | |
| CAMPHOR (NATURAL) | ACTIVE MOIETY | N20HL7Q941 | 9 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 9 | |
| C13-14 Isoparaffin | INACTIVE INGREDIENT | E4F12ROE70 | 9 | |
| Caprylyl glycol | INACTIVE INGREDIENT | 00YIU5438U | 9 | |
| Cetyl alcohol | INACTIVE INGREDIENT | 936JST6JCN | 9 | |
| Chondroitin sulfate (bovine) | INACTIVE INGREDIENT | 6IC1M3OG5Z | 9 | |
| CUCUMARIA SEA CUCUMBER | INACTIVE INGREDIENT | 3SC3X5I2GC | 9 | |
| Dimethyl sulfone | INACTIVE INGREDIENT | 9H4PO4Z4FT | 9 | |
| Eucalyptus oil | INACTIVE INGREDIENT | 2R04ONI662 | 9 | |
| Glucosamine sulfate | INACTIVE INGREDIENT | 1FW7WLR731 | 9 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 9 | |
| Glycol stearate | INACTIVE INGREDIENT | 0324G66D0E | 9 | |
| Grape seed oil | INACTIVE INGREDIENT | 930MLC8XGG | 9 | |
| LAVANDULA ANGUSTIFOLIA FLOWER | INACTIVE INGREDIENT | 19AH1RAF4M | 9 | |
| Methyl salicylate | INACTIVE INGREDIENT | LAV5U5022Y | 9 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 9 | |
| Polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 9 | |
| Sorbic acid | INACTIVE INGREDIENT | X045WJ989B | 9 | |
| Stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 9 | |
| Thymol | INACTIVE INGREDIENT | 3J50XA376E | 9 | |
| Urea | INACTIVE INGREDIENT | 8W8T17847W | 9 | |
| Vitamin E | INACTIVE INGREDIENT | H4N855PNZ1 | 9 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 9 |
Products#
Every source-derived product name is available through these pages.
- Pro-Flex
- Camphor, Menthol
- CAMPHOR (NATURAL)
- Menthol
- Water
- Cetyl alcohol
- Glycol stearate
- Dimethyl sulfone
- Glycerin
- Stearyl alcohol
- Glucosamine sulfate
- C13-14 Isoparaffin
- Polysorbate 20
- Urea
- Phenoxyethanol
- Caprylyl glycol
- Sorbic acid
- Eucalyptus oil
- Methyl salicylate
- Vitamin E
- LAVANDULA ANGUSTIFOLIA FLOWER
- Thymol
- Chondroitin sulfate (bovine)
- CUCUMARIA SEA CUCUMBER
- Grape seed oil
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49795-227 | 49795-227-01, 49795-227-02, 49795-227-03 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | OINTMENT / TOPICAL | 0.1 %w/w | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SPRAY, METERED / NASAL | 40 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CAPSULE, EXTENDED RELEASE / ORAL | 72 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | SYRUP / ORAL | 80 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / ORAL | 80 mg | ||
| Thymol | THYMOL | 3J50XA376E | LIQUID / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / TOPICAL | 82 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | SOLUTION / OPHTHALMIC | 0.2 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | POWDER, FOR SUSPENSION / ORAL | 1.3 mg/5ml | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | LOTION / TOPICAL | 2000 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / TOPICAL | 2.01 %w/w | ||
| Urea | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| Urea | UREA | 8W8T17847W | TABLET, COATED / ORAL | 0.02 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | GEL / TOPICAL | 2 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAMUSCULAR | 1.62 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUPPOSITORY / VAGINAL | NA | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CREAM / TOPICAL | 162000 mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 59 mg | ||
| Urea | UREA | 8W8T17847W | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / AURICULAR (OTIC) | 0.1 %w/v | ||
| Vitamin E | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| Methyl salicylate | METHYL SALICYLATE | LAV5U5022Y | TABLET / ORAL | 10 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, EXTENDED RELEASE / ORAL | 4.2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET / ORAL | 17 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 60 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SHAMPOO / TOPICAL | 8 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SOAP / TOPICAL | 0.02 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | TABLET, CHEWABLE / ORAL | NA | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | EMULSION / OPHTHALMIC | 1 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CREAM / VAGINAL | 425 mg | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | SOLUTION / ORAL | 80 mg | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | TABLET, FILM COATED / ORAL | 5 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET, EXTENDED RELEASE / ORAL | 244 mg | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | TABLET, COATED / ORAL | 1 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| Methyl salicylate | METHYL SALICYLATE | LAV5U5022Y | PASTE, DENTIFRICE / DENTAL | 1.1 %w/w | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CAPSULE, DELAYED RELEASE / ORAL | 59 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / VAGINAL | 200 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 435741fe-09ac-9ecf-e063-6394a90adbce | 3ca7e006-069f-4991-b457-6d4501673d78 | 2025-11-11 | Warnings | 3ca7e006-069f-4991-b457-6d4501673d78 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.